Eva Hammerby

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Allergic Rhinitis

Health Risk Assessment

Replacement Therapy

Top Venues

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne K Ellis, Douglas P Mack, Rémi Gagnon, Eva Hammerby, Sheena Gosain
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19 (1) (2023)
Hamelmann Eckard, Eva Hammerby, Katrine Skaarup Scharling, Mikkel Pedersen, Anna Okkels, Jochen Schmitt
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children. Allergy 79 (4) (2023)
Anne K Ellis, Douglas P Mack, Rémi Gagnon, Eva Hammerby, Sheena Gosain
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 19 (1) (2023)
Hamelmann Eckard, Eva Hammerby, Katrine Skaarup Scharling, Mikkel Pedersen, Anna Okkels, Jochen Schmitt
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children. Allergy 79 (4) (2023)
Hamelmann Eckard, Eva Hammerby, Katrine Skaarup Scharling, Mikkel Pedersen, Anna Okkels, Jochen Schmitt
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children. Allergy 79 (4) (2023)
Hamelmann Eckard, Eva Hammerby, Katrine Skaarup Scharling, Mikkel Pedersen, Anna Okkels, Jochen Schmitt
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children. Allergy (2023)
Hamelmann Eckard, Eva Hammerby, Katrine Skaarup Scharling, Mikkel Pedersen, Anna Okkels, Jochen Schmitt
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children. Allergy 79 (4) (2023)
Anne K Ellis, Rémi Gagnon, Eva Hammerby, Julia Shen, Sheena Gosain
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 17 (1) (2021)
Anne K Ellis, Rémi Gagnon, Eva Hammerby, Andrea Lau
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs? Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 15 (2019)